Cara Therapeutics Inc
NASDAQ:CARA

Watchlist Manager
Cara Therapeutics Inc Logo
Cara Therapeutics Inc
NASDAQ:CARA
Watchlist
Price: 18.2486 USD 243.02% Market Closed
Market Cap: 83.4m USD

Intrinsic Value

The intrinsic value of one CARA stock under the Base Case scenario is hidden USD. Compared to the current market price of 18.2486 USD, Cara Therapeutics Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

CARA Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Cara Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

CARA looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether CARA usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about CARA?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CARA valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Cara Therapeutics Inc.

Explain Valuation
Compare CARA to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CARA?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cara Therapeutics Inc

Current Assets 43.8m
Cash & Short-Term Investments 37.9m
Receivables 4.5m
Other Current Assets 1.4m
Current Liabilities 4m
Accounts Payable 1.4m
Accrued Liabilities 2.5m
Non-Current Liabilities 44.4m
Other Non-Current Liabilities 44.4m
Efficiency

Free Cash Flow Analysis
Cara Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cara Therapeutics Inc

Revenue
7.1m USD
Cost of Revenue
-620k USD
Gross Profit
6.5m USD
Operating Expenses
-59.3m USD
Operating Income
-52.8m USD
Other Expenses
-18m USD
Net Income
-70.9m USD
Fundamental Scores

CARA Profitability Score
Profitability Due Diligence

Cara Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Gross Margin is Increasing
Declining Net Margin
hidden
Profitability
Score

Cara Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

CARA Solvency Score
Solvency Due Diligence

Cara Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Low Altman Z-Score
hidden
Solvency
Score

Cara Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CARA Price Targets Summary
Cara Therapeutics Inc

There are no price targets for CARA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Cara Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CARA is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CARA Insider Trading
Buy and sell transactions by insiders

CARA News

Other Videos
What is the Intrinsic Value of one CARA stock?

The intrinsic value of one CARA stock under the Base Case scenario is hidden USD.

Is CARA stock undervalued or overvalued?

Compared to the current market price of 18.2486 USD, Cara Therapeutics Inc is hidden .

Back to Top